AAMFM, an Antigen-specific Antibody Multimodal Foundation Model that learns unified representations of antibody sequences and structures conditioned on antigen context, achieves state-of-the-art performance in functional antibody design, revealing its potential for antigen-specific antibody engineering.
Abstract
Antibodies are essential proteins that play a central role in immune recognition by binding specific antigen molecules. Although recent protein language models have enabled progress in single-chain protein modeling and generation, they often fall short in antigen-specific antibody design, where effective modeling requires explicit pairing between antibody and antigen, particularly at the epitope level. To address these limitations, we introduce AAMFM, an Antigen-specific Antibody Multimodal Foundation Model that learns unified representations of antibody sequences and structures conditioned on antigen context. AAMFM incorporates rich antigen information including geometric interfaces and epitope annotations via a cross-modal adapter, enabling joint modeling of antibody-antigen interactions in a shared latent space. To further guide the model toward functional relevance, we fine-tune AAMFM using Calibrated Direct Preference Optimization (Cal-DPO), leveraging preference signals extracted from a strong structural prior to align learning with binding-specific objectives. Extensive experiments demonstrate that AAMFM achieves state-of-the-art performance in functional antibody design, revealing its potential for antigen-specific antibody engineering. Our code is available at https://github.com/XL-S224/AAMFM.
This work designs a biological prior-guided feature fusion framework that integrates pseudo-structural epitope knowledge and CDR-specific attention mechanisms via a mixture-of-experts architecture to effectively capture complex binding landscapes in antibody screening and drug residence time analysis.
G. Luo, Junkai Wang, Sizhe Zhang et al.· Bioinformatics· 0 citations
AbICL is proposed, an ICL framework for antigen-specific antibody affinity ranking that combines a pretrained structural encoder with a context ranking head and is trained with an episodic meta-training strategy that enables the model to leverage support demonstrations for test-time adaptation without gradient updates.
Zhiyuan Chen, Jing Hu, Junzhe Wang et al.· 0 citations
CASLR is proposed, an antibody CDR-aware slot late-interaction retriever that encodes antigens with ESM-2, encodes antibodies with IgBert, constrains antibody-side latent slots to complementarity-determining regions (CDRs), and scores local slot compatibility instead of single-vector global similarity.
Peishuo Liu, Mianzhi Pan, Chenyang Yan et al.· bioRxiv· 0 citations
SAASBench provides a framework for evaluating the model's ability to estimate the specificity of a candidate antibody in relevant settings, indicating that strong performance on traditional affinity benchmarks does not automatically translate into reliable antibody specificity estimation in proteome-derived settings.
Dmitriy Umerenkov, Ivan Poddiakov· Proceedings of the 32nd ACM...· 0 citations
It is shown that increased sampling and AlphaFold3 generally improve performance relative to default sampling and AlphaFold2, however predictive accuracy and improvement levels varied considerably among interface classes, with antibody-peptide complexes representing a challenge despite their small antigen size.
Rui Yin, S. Saravanakumar, S. Shi et al.· bioRxiv· 1 citation
This work proposes MochiBind, a sequence-only pairwise binding affinity predictor, and benchmark it against structure-derived baselines such as Boltz-2, GeoDock, and Graphinity, suggesting that sequence-based approaches can match or surpass structure-based models in generalization.
Yunrui Li, Yue Zhao, K. Sonmez et al.· iScience· 0 citations